City Holding Co. Has $4.95 Million Stock Position in UnitedHealth Group Incorporated $UNH

City Holding Co. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 24.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,863 shares of the healthcare conglomerate’s stock after purchasing an additional 3,088 shares during the quarter. City Holding Co.’s holdings in UnitedHealth Group were worth $4,948,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bath Savings Trust Co raised its stake in shares of UnitedHealth Group by 7.3% during the 1st quarter. Bath Savings Trust Co now owns 761 shares of the healthcare conglomerate’s stock worth $399,000 after purchasing an additional 52 shares in the last quarter. Retirement Wealth Solutions LLC raised its stake in UnitedHealth Group by 55.0% in the 1st quarter. Retirement Wealth Solutions LLC now owns 186 shares of the healthcare conglomerate’s stock valued at $97,000 after acquiring an additional 66 shares during the period. Finally, IFG Advisors LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at $200,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.4%

Shares of UnitedHealth Group stock opened at $344.15 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a 50 day moving average price of $301.20 and a two-hundred day moving average price of $359.58. The stock has a market capitalization of $311.69 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 2.24 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Finally, Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.